MINT-E · M602011085
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial with extension period to evaluate the efficacy and safety of Xeomin® injections for the prevention of episodic migraine. EudraCT: 2024-515715-22-00
Sponsor: MERZ
Phase: III
Area: Headache disorders